InspireMD (NASDAQ:NSPR) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.20) by 20 percent. The company reported quarterly sales of $1.810 million which beat the analyst consensus estimate of $1.740 million by 4.02 percent. This is a 16.32 percent increase over sales of $1.556 million the same period last year.